Webster Bank, N. A. Nymox Pharmaceutical Corp Transaction History

Webster Bank, N. A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	BUY	$1.46 - $2.48 $14,600 - $24,800	10,000 Added 14.29%	80,000 $126,000
Q3 2020 Oct 22, 2020	BUY	$2.3 - $3.66 $23,000 - $36,600	10,000 Added 16.67%	70,000 $172,000
Q3 2018 Oct 12, 2018	BUY	$2.46 - $3.7 $24,600 - $37,000	10,000 Added 20.0%	60,000 $148,000
Q3 2017 Oct 12, 2017	BUY	$3.36 - $4.02 $168,000 - $200,999	50,000	50,000 $191,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Webster Bank, N. A., based on Form 13F filings with the SEC.

Stay updated on Webster Bank, N. A. with notifications on news.